Global AI-Designed Small-Molecule Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global AI-Designed Small-Molecule Drugs market size was valued at US$ 1321 million in 2025 and is forecast to a readjusted size of US$ 6010 million by 2032 with a CAGR of 24.2% during review period.
AI-designed small-molecule drugs are synthesizable and developable drug candidates for which machine learning, generative AI, and physics-based modeling make a material contribution to target identification, virtual screening, molecular generation, structure?activity optimization, or ADMET prediction. They are supplied as discovery-stage molecules, preclinical candidates, clinical pipeline assets, or licensed programs and are evaluated by target novelty, potency and selectivity, oral exposure, tissue distribution, safety margin, manufacturability, and intellectual property. Major uses include oncology, immunology and inflammation, neurology, metabolic disease, and infectious disease research. The market scope covers related R&D spending, collaboration revenue, upfront licensing payments, and milestone value rather than end-market prescription drug sales, with an estimated blended gross margin of about 68%.
Demand is driven by pharmaceutical companies seeking to shorten early discovery cycles, expand the range of druggable targets, and improve the quality of candidates entering clinical development. Oncology, immunology and inflammation, neurology, and metabolic diseases are the first areas to build dense AI-enabled pipelines because they combine substantial unmet need with increasingly rich target and molecular data. Demand is particularly strong for oral therapies, brain-penetrant compounds, mutation-selective inhibitors, and programs against historically difficult targets.
Competition is moving beyond stand-alone virtual screening toward closed loops that connect target discovery, generative design, automated synthesis, experimental validation, and clinical translation. Leading suppliers are building proprietary datasets, physics-based simulation, foundation models, and wet-lab infrastructure while validating their systems through internal pipelines and pharmaceutical partnerships. Product development is advancing toward simultaneous multiparameter optimization, more reliable selectivity and toxicity prediction, protein dynamics modeling, active learning, and exploration of new chemical space for protein degradation and nucleic-acid targets.
North America continues to concentrate most AI-native drug developers, capital, and large-pharma partnerships, while the United Kingdom, France, and China are building differentiated capabilities in generative chemistry, structure prediction, laboratory automation, and clinical execution. Customers increasingly evaluate suppliers by delivered candidates, clinical milestones, data feedback loops, and intellectual-property boundaries rather than model benchmarks alone. Key risks include long clinical validation cycles, biased training data, limited synthetic feasibility, and complex ownership of partnered assets. Companies with end-to-end development capability, repeatable delivery records, and cross-regional clinical resources are better positioned to secure licensing and co-development opportunities.
Report Scope
This report is a detailed and comprehensive analysis for global AI-Designed Small-Molecule Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI-Designed Small-Molecule Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global AI-Designed Small-Molecule Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global AI-Designed Small-Molecule Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global AI-Designed Small-Molecule Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
AI-Designed Small-Molecule Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe AI-Designed Small-Molecule Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of AI-Designed Small-Molecule Drugs, with price, sales quantity, revenue, and global market share of AI-Designed Small-Molecule Drugs from 2021 to 2026.
Chapter 3, the AI-Designed Small-Molecule Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AI-Designed Small-Molecule Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and AI-Designed Small-Molecule Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of AI-Designed Small-Molecule Drugs.
Chapter 14 and 15, to describe AI-Designed Small-Molecule Drugs sales channel, distributors, customers, research findings and conclusion.
AI-designed small-molecule drugs are synthesizable and developable drug candidates for which machine learning, generative AI, and physics-based modeling make a material contribution to target identification, virtual screening, molecular generation, structure?activity optimization, or ADMET prediction. They are supplied as discovery-stage molecules, preclinical candidates, clinical pipeline assets, or licensed programs and are evaluated by target novelty, potency and selectivity, oral exposure, tissue distribution, safety margin, manufacturability, and intellectual property. Major uses include oncology, immunology and inflammation, neurology, metabolic disease, and infectious disease research. The market scope covers related R&D spending, collaboration revenue, upfront licensing payments, and milestone value rather than end-market prescription drug sales, with an estimated blended gross margin of about 68%.
Demand is driven by pharmaceutical companies seeking to shorten early discovery cycles, expand the range of druggable targets, and improve the quality of candidates entering clinical development. Oncology, immunology and inflammation, neurology, and metabolic diseases are the first areas to build dense AI-enabled pipelines because they combine substantial unmet need with increasingly rich target and molecular data. Demand is particularly strong for oral therapies, brain-penetrant compounds, mutation-selective inhibitors, and programs against historically difficult targets.
Competition is moving beyond stand-alone virtual screening toward closed loops that connect target discovery, generative design, automated synthesis, experimental validation, and clinical translation. Leading suppliers are building proprietary datasets, physics-based simulation, foundation models, and wet-lab infrastructure while validating their systems through internal pipelines and pharmaceutical partnerships. Product development is advancing toward simultaneous multiparameter optimization, more reliable selectivity and toxicity prediction, protein dynamics modeling, active learning, and exploration of new chemical space for protein degradation and nucleic-acid targets.
North America continues to concentrate most AI-native drug developers, capital, and large-pharma partnerships, while the United Kingdom, France, and China are building differentiated capabilities in generative chemistry, structure prediction, laboratory automation, and clinical execution. Customers increasingly evaluate suppliers by delivered candidates, clinical milestones, data feedback loops, and intellectual-property boundaries rather than model benchmarks alone. Key risks include long clinical validation cycles, biased training data, limited synthetic feasibility, and complex ownership of partnered assets. Companies with end-to-end development capability, repeatable delivery records, and cross-regional clinical resources are better positioned to secure licensing and co-development opportunities.
Report Scope
This report is a detailed and comprehensive analysis for global AI-Designed Small-Molecule Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global AI-Designed Small-Molecule Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global AI-Designed Small-Molecule Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global AI-Designed Small-Molecule Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Dose), and average selling prices (US$/Dose), 2021-2032
Global AI-Designed Small-Molecule Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Dose), and ASP (US$/Dose), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for AI-Designed Small-Molecule Drugs
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
AI-Designed Small-Molecule Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Discovery-Stage Candidates
- Preclinical Candidates
- Clinical-Stage Candidates
- Approved Drugs
- Enzyme Inhibitors
- Receptor Agonists
- Receptor Antagonists
- Targeted Protein Degraders
- Molecular Glues
- Other Small-Molecule Modulators
- Oral Drugs
- Injectable Drugs
- Inhaled Drugs
- Topical Drugs
- Other Administration Routes
- Kinases
- Other Enzymes
- G Protein-Coupled Receptors
- Nuclear Receptors
- Protein?Protein Interaction Targets
- Nucleic Acid Targets
- Other Target Classes
- Oncology
- Immunology and Inflammation
- Neurology and Psychiatry
- Metabolic and Cardiovascular Diseases
- Infectious Diseases
- Other Therapeutic Areas
- Recursion Pharmaceuticals
- Insilico Medicine
- Schr?dinger
- XtalPi
- Isomorphic Labs
- Relay Therapeutics
- Nimbus Therapeutics
- Iambic Therapeutics
- BenevolentAI
- Accutar Biotechnology
- MindRank AI
- Enveda Biosciences
- Insitro
- Valo Health
- Healx
- Lantern Pharma
- Verge Labs
- DeepCure
- AQEMIA
- Genesis Molecular AI
- Terray Therapeutics
- CHARM Therapeutics
- Anagenex
- StoneWise
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe AI-Designed Small-Molecule Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of AI-Designed Small-Molecule Drugs, with price, sales quantity, revenue, and global market share of AI-Designed Small-Molecule Drugs from 2021 to 2026.
Chapter 3, the AI-Designed Small-Molecule Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the AI-Designed Small-Molecule Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and AI-Designed Small-Molecule Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of AI-Designed Small-Molecule Drugs.
Chapter 14 and 15, to describe AI-Designed Small-Molecule Drugs sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Discovery-Stage Candidates
1.3.3 Preclinical Candidates
1.3.4 Clinical-Stage Candidates
1.3.5 Approved Drugs
1.4 Market Analysis by Mechanism of Action
1.4.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Mechanism of Action: 2021 Versus 2025 Versus 2032
1.4.2 Enzyme Inhibitors
1.4.3 Receptor Agonists
1.4.4 Receptor Antagonists
1.4.5 Targeted Protein Degraders
1.4.6 Molecular Glues
1.4.7 Other Small-Molecule Modulators
1.5 Market Analysis by Route of Administration
1.5.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Route of Administration: 2021 Versus 2025 Versus 2032
1.5.2 Oral Drugs
1.5.3 Injectable Drugs
1.5.4 Inhaled Drugs
1.5.5 Topical Drugs
1.5.6 Other Administration Routes
1.6 Market Analysis by Target Class
1.6.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Target Class: 2021 Versus 2025 Versus 2032
1.6.2 Kinases
1.6.3 Other Enzymes
1.6.4 G Protein-Coupled Receptors
1.6.5 Nuclear Receptors
1.6.6 Protein?Protein Interaction Targets
1.6.7 Nucleic Acid Targets
1.6.8 Other Target Classes
1.7 Market Analysis by Application
1.7.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Oncology
1.7.3 Immunology and Inflammation
1.7.4 Neurology and Psychiatry
1.7.5 Metabolic and Cardiovascular Diseases
1.7.6 Infectious Diseases
1.7.7 Other Therapeutic Areas
1.8 Global AI-Designed Small-Molecule Drugs Market Size & Forecast
1.8.1 Global AI-Designed Small-Molecule Drugs Consumption Value (2021 & 2025 & 2032)
1.8.2 Global AI-Designed Small-Molecule Drugs Sales Quantity (2021-2032)
1.8.3 Global AI-Designed Small-Molecule Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Recursion Pharmaceuticals
2.1.1 Recursion Pharmaceuticals Details
2.1.2 Recursion Pharmaceuticals Major Business
2.1.3 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product and Services
2.1.4 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Recursion Pharmaceuticals Recent Developments/Updates
2.2 Insilico Medicine
2.2.1 Insilico Medicine Details
2.2.2 Insilico Medicine Major Business
2.2.3 Insilico Medicine AI-Designed Small-Molecule Drugs Product and Services
2.2.4 Insilico Medicine AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Insilico Medicine Recent Developments/Updates
2.3 Schr?dinger
2.3.1 Schr?dinger Details
2.3.2 Schr?dinger Major Business
2.3.3 Schr?dinger AI-Designed Small-Molecule Drugs Product and Services
2.3.4 Schr?dinger AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Schr?dinger Recent Developments/Updates
2.4 XtalPi
2.4.1 XtalPi Details
2.4.2 XtalPi Major Business
2.4.3 XtalPi AI-Designed Small-Molecule Drugs Product and Services
2.4.4 XtalPi AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 XtalPi Recent Developments/Updates
2.5 Isomorphic Labs
2.5.1 Isomorphic Labs Details
2.5.2 Isomorphic Labs Major Business
2.5.3 Isomorphic Labs AI-Designed Small-Molecule Drugs Product and Services
2.5.4 Isomorphic Labs AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Isomorphic Labs Recent Developments/Updates
2.6 Relay Therapeutics
2.6.1 Relay Therapeutics Details
2.6.2 Relay Therapeutics Major Business
2.6.3 Relay Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.6.4 Relay Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Relay Therapeutics Recent Developments/Updates
2.7 Nimbus Therapeutics
2.7.1 Nimbus Therapeutics Details
2.7.2 Nimbus Therapeutics Major Business
2.7.3 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.7.4 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nimbus Therapeutics Recent Developments/Updates
2.8 Iambic Therapeutics
2.8.1 Iambic Therapeutics Details
2.8.2 Iambic Therapeutics Major Business
2.8.3 Iambic Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.8.4 Iambic Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Iambic Therapeutics Recent Developments/Updates
2.9 BenevolentAI
2.9.1 BenevolentAI Details
2.9.2 BenevolentAI Major Business
2.9.3 BenevolentAI AI-Designed Small-Molecule Drugs Product and Services
2.9.4 BenevolentAI AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 BenevolentAI Recent Developments/Updates
2.10 Accutar Biotechnology
2.10.1 Accutar Biotechnology Details
2.10.2 Accutar Biotechnology Major Business
2.10.3 Accutar Biotechnology AI-Designed Small-Molecule Drugs Product and Services
2.10.4 Accutar Biotechnology AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Accutar Biotechnology Recent Developments/Updates
2.11 MindRank AI
2.11.1 MindRank AI Details
2.11.2 MindRank AI Major Business
2.11.3 MindRank AI AI-Designed Small-Molecule Drugs Product and Services
2.11.4 MindRank AI AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 MindRank AI Recent Developments/Updates
2.12 Enveda Biosciences
2.12.1 Enveda Biosciences Details
2.12.2 Enveda Biosciences Major Business
2.12.3 Enveda Biosciences AI-Designed Small-Molecule Drugs Product and Services
2.12.4 Enveda Biosciences AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Enveda Biosciences Recent Developments/Updates
2.13 Insitro
2.13.1 Insitro Details
2.13.2 Insitro Major Business
2.13.3 Insitro AI-Designed Small-Molecule Drugs Product and Services
2.13.4 Insitro AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Insitro Recent Developments/Updates
2.14 Valo Health
2.14.1 Valo Health Details
2.14.2 Valo Health Major Business
2.14.3 Valo Health AI-Designed Small-Molecule Drugs Product and Services
2.14.4 Valo Health AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Valo Health Recent Developments/Updates
2.15 Healx
2.15.1 Healx Details
2.15.2 Healx Major Business
2.15.3 Healx AI-Designed Small-Molecule Drugs Product and Services
2.15.4 Healx AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Healx Recent Developments/Updates
2.16 Lantern Pharma
2.16.1 Lantern Pharma Details
2.16.2 Lantern Pharma Major Business
2.16.3 Lantern Pharma AI-Designed Small-Molecule Drugs Product and Services
2.16.4 Lantern Pharma AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Lantern Pharma Recent Developments/Updates
2.17 Verge Labs
2.17.1 Verge Labs Details
2.17.2 Verge Labs Major Business
2.17.3 Verge Labs AI-Designed Small-Molecule Drugs Product and Services
2.17.4 Verge Labs AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Verge Labs Recent Developments/Updates
2.18 DeepCure
2.18.1 DeepCure Details
2.18.2 DeepCure Major Business
2.18.3 DeepCure AI-Designed Small-Molecule Drugs Product and Services
2.18.4 DeepCure AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 DeepCure Recent Developments/Updates
2.19 AQEMIA
2.19.1 AQEMIA Details
2.19.2 AQEMIA Major Business
2.19.3 AQEMIA AI-Designed Small-Molecule Drugs Product and Services
2.19.4 AQEMIA AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 AQEMIA Recent Developments/Updates
2.20 Genesis Molecular AI
2.20.1 Genesis Molecular AI Details
2.20.2 Genesis Molecular AI Major Business
2.20.3 Genesis Molecular AI AI-Designed Small-Molecule Drugs Product and Services
2.20.4 Genesis Molecular AI AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Genesis Molecular AI Recent Developments/Updates
2.21 Terray Therapeutics
2.21.1 Terray Therapeutics Details
2.21.2 Terray Therapeutics Major Business
2.21.3 Terray Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.21.4 Terray Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Terray Therapeutics Recent Developments/Updates
2.22 CHARM Therapeutics
2.22.1 CHARM Therapeutics Details
2.22.2 CHARM Therapeutics Major Business
2.22.3 CHARM Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.22.4 CHARM Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 CHARM Therapeutics Recent Developments/Updates
2.23 Anagenex
2.23.1 Anagenex Details
2.23.2 Anagenex Major Business
2.23.3 Anagenex AI-Designed Small-Molecule Drugs Product and Services
2.23.4 Anagenex AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Anagenex Recent Developments/Updates
2.24 StoneWise
2.24.1 StoneWise Details
2.24.2 StoneWise Major Business
2.24.3 StoneWise AI-Designed Small-Molecule Drugs Product and Services
2.24.4 StoneWise AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 StoneWise Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: AI-DESIGNED SMALL-MOLECULE DRUGS BY MANUFACTURER
3.1 Global AI-Designed Small-Molecule Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global AI-Designed Small-Molecule Drugs Revenue by Manufacturer (2021-2026)
3.3 Global AI-Designed Small-Molecule Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of AI-Designed Small-Molecule Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 AI-Designed Small-Molecule Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 AI-Designed Small-Molecule Drugs Manufacturer Market Share in 2025
3.5 AI-Designed Small-Molecule Drugs Market: Overall Company Footprint Analysis
3.5.1 AI-Designed Small-Molecule Drugs Market: Region Footprint
3.5.2 AI-Designed Small-Molecule Drugs Market: Company Product Type Footprint
3.5.3 AI-Designed Small-Molecule Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global AI-Designed Small-Molecule Drugs Market Size by Region
4.1.1 Global AI-Designed Small-Molecule Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2032)
4.1.3 Global AI-Designed Small-Molecule Drugs Average Price by Region (2021-2032)
4.2 North America AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
4.3 Europe AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
4.5 South America AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
5.2 Global AI-Designed Small-Molecule Drugs Consumption Value by Type (2021-2032)
5.3 Global AI-Designed Small-Molecule Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
6.2 Global AI-Designed Small-Molecule Drugs Consumption Value by Application (2021-2032)
6.3 Global AI-Designed Small-Molecule Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
7.2 North America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
7.3 North America AI-Designed Small-Molecule Drugs Market Size by Country
7.3.1 North America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
8.2 Europe AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
8.3 Europe AI-Designed Small-Molecule Drugs Market Size by Country
8.3.1 Europe AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific AI-Designed Small-Molecule Drugs Market Size by Region
9.3.1 Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
10.2 South America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
10.3 South America AI-Designed Small-Molecule Drugs Market Size by Country
10.3.1 South America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa AI-Designed Small-Molecule Drugs Market Size by Country
11.3.1 Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 AI-Designed Small-Molecule Drugs Market Drivers
12.2 AI-Designed Small-Molecule Drugs Market Restraints
12.3 AI-Designed Small-Molecule Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of AI-Designed Small-Molecule Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of AI-Designed Small-Molecule Drugs
13.3 AI-Designed Small-Molecule Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 AI-Designed Small-Molecule Drugs Typical Distributors
14.3 AI-Designed Small-Molecule Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
1.3.2 Discovery-Stage Candidates
1.3.3 Preclinical Candidates
1.3.4 Clinical-Stage Candidates
1.3.5 Approved Drugs
1.4 Market Analysis by Mechanism of Action
1.4.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Mechanism of Action: 2021 Versus 2025 Versus 2032
1.4.2 Enzyme Inhibitors
1.4.3 Receptor Agonists
1.4.4 Receptor Antagonists
1.4.5 Targeted Protein Degraders
1.4.6 Molecular Glues
1.4.7 Other Small-Molecule Modulators
1.5 Market Analysis by Route of Administration
1.5.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Route of Administration: 2021 Versus 2025 Versus 2032
1.5.2 Oral Drugs
1.5.3 Injectable Drugs
1.5.4 Inhaled Drugs
1.5.5 Topical Drugs
1.5.6 Other Administration Routes
1.6 Market Analysis by Target Class
1.6.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Target Class: 2021 Versus 2025 Versus 2032
1.6.2 Kinases
1.6.3 Other Enzymes
1.6.4 G Protein-Coupled Receptors
1.6.5 Nuclear Receptors
1.6.6 Protein?Protein Interaction Targets
1.6.7 Nucleic Acid Targets
1.6.8 Other Target Classes
1.7 Market Analysis by Application
1.7.1 Overview: Global AI-Designed Small-Molecule Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
1.7.2 Oncology
1.7.3 Immunology and Inflammation
1.7.4 Neurology and Psychiatry
1.7.5 Metabolic and Cardiovascular Diseases
1.7.6 Infectious Diseases
1.7.7 Other Therapeutic Areas
1.8 Global AI-Designed Small-Molecule Drugs Market Size & Forecast
1.8.1 Global AI-Designed Small-Molecule Drugs Consumption Value (2021 & 2025 & 2032)
1.8.2 Global AI-Designed Small-Molecule Drugs Sales Quantity (2021-2032)
1.8.3 Global AI-Designed Small-Molecule Drugs Average Price (2021-2032)
2 MANUFACTURERS PROFILES
2.1 Recursion Pharmaceuticals
2.1.1 Recursion Pharmaceuticals Details
2.1.2 Recursion Pharmaceuticals Major Business
2.1.3 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product and Services
2.1.4 Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Recursion Pharmaceuticals Recent Developments/Updates
2.2 Insilico Medicine
2.2.1 Insilico Medicine Details
2.2.2 Insilico Medicine Major Business
2.2.3 Insilico Medicine AI-Designed Small-Molecule Drugs Product and Services
2.2.4 Insilico Medicine AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Insilico Medicine Recent Developments/Updates
2.3 Schr?dinger
2.3.1 Schr?dinger Details
2.3.2 Schr?dinger Major Business
2.3.3 Schr?dinger AI-Designed Small-Molecule Drugs Product and Services
2.3.4 Schr?dinger AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Schr?dinger Recent Developments/Updates
2.4 XtalPi
2.4.1 XtalPi Details
2.4.2 XtalPi Major Business
2.4.3 XtalPi AI-Designed Small-Molecule Drugs Product and Services
2.4.4 XtalPi AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 XtalPi Recent Developments/Updates
2.5 Isomorphic Labs
2.5.1 Isomorphic Labs Details
2.5.2 Isomorphic Labs Major Business
2.5.3 Isomorphic Labs AI-Designed Small-Molecule Drugs Product and Services
2.5.4 Isomorphic Labs AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Isomorphic Labs Recent Developments/Updates
2.6 Relay Therapeutics
2.6.1 Relay Therapeutics Details
2.6.2 Relay Therapeutics Major Business
2.6.3 Relay Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.6.4 Relay Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Relay Therapeutics Recent Developments/Updates
2.7 Nimbus Therapeutics
2.7.1 Nimbus Therapeutics Details
2.7.2 Nimbus Therapeutics Major Business
2.7.3 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.7.4 Nimbus Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Nimbus Therapeutics Recent Developments/Updates
2.8 Iambic Therapeutics
2.8.1 Iambic Therapeutics Details
2.8.2 Iambic Therapeutics Major Business
2.8.3 Iambic Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.8.4 Iambic Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 Iambic Therapeutics Recent Developments/Updates
2.9 BenevolentAI
2.9.1 BenevolentAI Details
2.9.2 BenevolentAI Major Business
2.9.3 BenevolentAI AI-Designed Small-Molecule Drugs Product and Services
2.9.4 BenevolentAI AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 BenevolentAI Recent Developments/Updates
2.10 Accutar Biotechnology
2.10.1 Accutar Biotechnology Details
2.10.2 Accutar Biotechnology Major Business
2.10.3 Accutar Biotechnology AI-Designed Small-Molecule Drugs Product and Services
2.10.4 Accutar Biotechnology AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Accutar Biotechnology Recent Developments/Updates
2.11 MindRank AI
2.11.1 MindRank AI Details
2.11.2 MindRank AI Major Business
2.11.3 MindRank AI AI-Designed Small-Molecule Drugs Product and Services
2.11.4 MindRank AI AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 MindRank AI Recent Developments/Updates
2.12 Enveda Biosciences
2.12.1 Enveda Biosciences Details
2.12.2 Enveda Biosciences Major Business
2.12.3 Enveda Biosciences AI-Designed Small-Molecule Drugs Product and Services
2.12.4 Enveda Biosciences AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.12.5 Enveda Biosciences Recent Developments/Updates
2.13 Insitro
2.13.1 Insitro Details
2.13.2 Insitro Major Business
2.13.3 Insitro AI-Designed Small-Molecule Drugs Product and Services
2.13.4 Insitro AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.13.5 Insitro Recent Developments/Updates
2.14 Valo Health
2.14.1 Valo Health Details
2.14.2 Valo Health Major Business
2.14.3 Valo Health AI-Designed Small-Molecule Drugs Product and Services
2.14.4 Valo Health AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.14.5 Valo Health Recent Developments/Updates
2.15 Healx
2.15.1 Healx Details
2.15.2 Healx Major Business
2.15.3 Healx AI-Designed Small-Molecule Drugs Product and Services
2.15.4 Healx AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.15.5 Healx Recent Developments/Updates
2.16 Lantern Pharma
2.16.1 Lantern Pharma Details
2.16.2 Lantern Pharma Major Business
2.16.3 Lantern Pharma AI-Designed Small-Molecule Drugs Product and Services
2.16.4 Lantern Pharma AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.16.5 Lantern Pharma Recent Developments/Updates
2.17 Verge Labs
2.17.1 Verge Labs Details
2.17.2 Verge Labs Major Business
2.17.3 Verge Labs AI-Designed Small-Molecule Drugs Product and Services
2.17.4 Verge Labs AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.17.5 Verge Labs Recent Developments/Updates
2.18 DeepCure
2.18.1 DeepCure Details
2.18.2 DeepCure Major Business
2.18.3 DeepCure AI-Designed Small-Molecule Drugs Product and Services
2.18.4 DeepCure AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.18.5 DeepCure Recent Developments/Updates
2.19 AQEMIA
2.19.1 AQEMIA Details
2.19.2 AQEMIA Major Business
2.19.3 AQEMIA AI-Designed Small-Molecule Drugs Product and Services
2.19.4 AQEMIA AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.19.5 AQEMIA Recent Developments/Updates
2.20 Genesis Molecular AI
2.20.1 Genesis Molecular AI Details
2.20.2 Genesis Molecular AI Major Business
2.20.3 Genesis Molecular AI AI-Designed Small-Molecule Drugs Product and Services
2.20.4 Genesis Molecular AI AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.20.5 Genesis Molecular AI Recent Developments/Updates
2.21 Terray Therapeutics
2.21.1 Terray Therapeutics Details
2.21.2 Terray Therapeutics Major Business
2.21.3 Terray Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.21.4 Terray Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.21.5 Terray Therapeutics Recent Developments/Updates
2.22 CHARM Therapeutics
2.22.1 CHARM Therapeutics Details
2.22.2 CHARM Therapeutics Major Business
2.22.3 CHARM Therapeutics AI-Designed Small-Molecule Drugs Product and Services
2.22.4 CHARM Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.22.5 CHARM Therapeutics Recent Developments/Updates
2.23 Anagenex
2.23.1 Anagenex Details
2.23.2 Anagenex Major Business
2.23.3 Anagenex AI-Designed Small-Molecule Drugs Product and Services
2.23.4 Anagenex AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.23.5 Anagenex Recent Developments/Updates
2.24 StoneWise
2.24.1 StoneWise Details
2.24.2 StoneWise Major Business
2.24.3 StoneWise AI-Designed Small-Molecule Drugs Product and Services
2.24.4 StoneWise AI-Designed Small-Molecule Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
2.24.5 StoneWise Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: AI-DESIGNED SMALL-MOLECULE DRUGS BY MANUFACTURER
3.1 Global AI-Designed Small-Molecule Drugs Sales Quantity by Manufacturer (2021-2026)
3.2 Global AI-Designed Small-Molecule Drugs Revenue by Manufacturer (2021-2026)
3.3 Global AI-Designed Small-Molecule Drugs Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of AI-Designed Small-Molecule Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 AI-Designed Small-Molecule Drugs Manufacturer Market Share in 2025
3.4.3 Top 6 AI-Designed Small-Molecule Drugs Manufacturer Market Share in 2025
3.5 AI-Designed Small-Molecule Drugs Market: Overall Company Footprint Analysis
3.5.1 AI-Designed Small-Molecule Drugs Market: Region Footprint
3.5.2 AI-Designed Small-Molecule Drugs Market: Company Product Type Footprint
3.5.3 AI-Designed Small-Molecule Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global AI-Designed Small-Molecule Drugs Market Size by Region
4.1.1 Global AI-Designed Small-Molecule Drugs Sales Quantity by Region (2021-2032)
4.1.2 Global AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2032)
4.1.3 Global AI-Designed Small-Molecule Drugs Average Price by Region (2021-2032)
4.2 North America AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
4.3 Europe AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
4.4 Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
4.5 South America AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
4.6 Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value (2021-2032)
5 MARKET SEGMENT BY TYPE
5.1 Global AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
5.2 Global AI-Designed Small-Molecule Drugs Consumption Value by Type (2021-2032)
5.3 Global AI-Designed Small-Molecule Drugs Average Price by Type (2021-2032)
6 MARKET SEGMENT BY APPLICATION
6.1 Global AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
6.2 Global AI-Designed Small-Molecule Drugs Consumption Value by Application (2021-2032)
6.3 Global AI-Designed Small-Molecule Drugs Average Price by Application (2021-2032)
7 NORTH AMERICA
7.1 North America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
7.2 North America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
7.3 North America AI-Designed Small-Molecule Drugs Market Size by Country
7.3.1 North America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2032)
7.3.2 North America AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2032)
7.3.3 United States Market Size and Forecast (2021-2032)
7.3.4 Canada Market Size and Forecast (2021-2032)
7.3.5 Mexico Market Size and Forecast (2021-2032)
8 EUROPE
8.1 Europe AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
8.2 Europe AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
8.3 Europe AI-Designed Small-Molecule Drugs Market Size by Country
8.3.1 Europe AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2032)
8.3.2 Europe AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2032)
8.3.3 Germany Market Size and Forecast (2021-2032)
8.3.4 France Market Size and Forecast (2021-2032)
8.3.5 United Kingdom Market Size and Forecast (2021-2032)
8.3.6 Russia Market Size and Forecast (2021-2032)
8.3.7 Italy Market Size and Forecast (2021-2032)
9 ASIA-PACIFIC
9.1 Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific AI-Designed Small-Molecule Drugs Market Size by Region
9.3.1 Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Region (2021-2032)
9.3.2 Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2032)
9.3.3 China Market Size and Forecast (2021-2032)
9.3.4 Japan Market Size and Forecast (2021-2032)
9.3.5 South Korea Market Size and Forecast (2021-2032)
9.3.6 India Market Size and Forecast (2021-2032)
9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
9.3.8 Australia Market Size and Forecast (2021-2032)
10 SOUTH AMERICA
10.1 South America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
10.2 South America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
10.3 South America AI-Designed Small-Molecule Drugs Market Size by Country
10.3.1 South America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2032)
10.3.2 South America AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2032)
10.3.3 Brazil Market Size and Forecast (2021-2032)
10.3.4 Argentina Market Size and Forecast (2021-2032)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa AI-Designed Small-Molecule Drugs Market Size by Country
11.3.1 Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2032)
11.3.2 Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2032)
11.3.3 Turkey Market Size and Forecast (2021-2032)
11.3.4 Egypt Market Size and Forecast (2021-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
11.3.6 South Africa Market Size and Forecast (2021-2032)
12 MARKET DYNAMICS
12.1 AI-Designed Small-Molecule Drugs Market Drivers
12.2 AI-Designed Small-Molecule Drugs Market Restraints
12.3 AI-Designed Small-Molecule Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of AI-Designed Small-Molecule Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of AI-Designed Small-Molecule Drugs
13.3 AI-Designed Small-Molecule Drugs Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 AI-Designed Small-Molecule Drugs Typical Distributors
14.3 AI-Designed Small-Molecule Drugs Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global AI-Designed Small-Molecule Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI-Designed Small-Molecule Drugs Consumption Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI-Designed Small-Molecule Drugs Consumption Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI-Designed Small-Molecule Drugs Consumption Value by Target Class, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI-Designed Small-Molecule Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 7. Recursion Pharmaceuticals Major Business
Table 8. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product and Services
Table 9. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Recursion Pharmaceuticals Recent Developments/Updates
Table 11. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 12. Insilico Medicine Major Business
Table 13. Insilico Medicine AI-Designed Small-Molecule Drugs Product and Services
Table 14. Insilico Medicine AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Insilico Medicine Recent Developments/Updates
Table 16. Schr?dinger Basic Information, Manufacturing Base and Competitors
Table 17. Schr?dinger Major Business
Table 18. Schr?dinger AI-Designed Small-Molecule Drugs Product and Services
Table 19. Schr?dinger AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Schr?dinger Recent Developments/Updates
Table 21. XtalPi Basic Information, Manufacturing Base and Competitors
Table 22. XtalPi Major Business
Table 23. XtalPi AI-Designed Small-Molecule Drugs Product and Services
Table 24. XtalPi AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. XtalPi Recent Developments/Updates
Table 26. Isomorphic Labs Basic Information, Manufacturing Base and Competitors
Table 27. Isomorphic Labs Major Business
Table 28. Isomorphic Labs AI-Designed Small-Molecule Drugs Product and Services
Table 29. Isomorphic Labs AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Isomorphic Labs Recent Developments/Updates
Table 31. Relay Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Relay Therapeutics Major Business
Table 33. Relay Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 34. Relay Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Relay Therapeutics Recent Developments/Updates
Table 36. Nimbus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 37. Nimbus Therapeutics Major Business
Table 38. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 39. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Nimbus Therapeutics Recent Developments/Updates
Table 41. Iambic Therapeutics Basic Information, Manufacturing Base and Competitors
Table 42. Iambic Therapeutics Major Business
Table 43. Iambic Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 44. Iambic Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Iambic Therapeutics Recent Developments/Updates
Table 46. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 47. BenevolentAI Major Business
Table 48. BenevolentAI AI-Designed Small-Molecule Drugs Product and Services
Table 49. BenevolentAI AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. BenevolentAI Recent Developments/Updates
Table 51. Accutar Biotechnology Basic Information, Manufacturing Base and Competitors
Table 52. Accutar Biotechnology Major Business
Table 53. Accutar Biotechnology AI-Designed Small-Molecule Drugs Product and Services
Table 54. Accutar Biotechnology AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Accutar Biotechnology Recent Developments/Updates
Table 56. MindRank AI Basic Information, Manufacturing Base and Competitors
Table 57. MindRank AI Major Business
Table 58. MindRank AI AI-Designed Small-Molecule Drugs Product and Services
Table 59. MindRank AI AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. MindRank AI Recent Developments/Updates
Table 61. Enveda Biosciences Basic Information, Manufacturing Base and Competitors
Table 62. Enveda Biosciences Major Business
Table 63. Enveda Biosciences AI-Designed Small-Molecule Drugs Product and Services
Table 64. Enveda Biosciences AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Enveda Biosciences Recent Developments/Updates
Table 66. Insitro Basic Information, Manufacturing Base and Competitors
Table 67. Insitro Major Business
Table 68. Insitro AI-Designed Small-Molecule Drugs Product and Services
Table 69. Insitro AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Insitro Recent Developments/Updates
Table 71. Valo Health Basic Information, Manufacturing Base and Competitors
Table 72. Valo Health Major Business
Table 73. Valo Health AI-Designed Small-Molecule Drugs Product and Services
Table 74. Valo Health AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Valo Health Recent Developments/Updates
Table 76. Healx Basic Information, Manufacturing Base and Competitors
Table 77. Healx Major Business
Table 78. Healx AI-Designed Small-Molecule Drugs Product and Services
Table 79. Healx AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Healx Recent Developments/Updates
Table 81. Lantern Pharma Basic Information, Manufacturing Base and Competitors
Table 82. Lantern Pharma Major Business
Table 83. Lantern Pharma AI-Designed Small-Molecule Drugs Product and Services
Table 84. Lantern Pharma AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Lantern Pharma Recent Developments/Updates
Table 86. Verge Labs Basic Information, Manufacturing Base and Competitors
Table 87. Verge Labs Major Business
Table 88. Verge Labs AI-Designed Small-Molecule Drugs Product and Services
Table 89. Verge Labs AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Verge Labs Recent Developments/Updates
Table 91. DeepCure Basic Information, Manufacturing Base and Competitors
Table 92. DeepCure Major Business
Table 93. DeepCure AI-Designed Small-Molecule Drugs Product and Services
Table 94. DeepCure AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. DeepCure Recent Developments/Updates
Table 96. AQEMIA Basic Information, Manufacturing Base and Competitors
Table 97. AQEMIA Major Business
Table 98. AQEMIA AI-Designed Small-Molecule Drugs Product and Services
Table 99. AQEMIA AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. AQEMIA Recent Developments/Updates
Table 101. Genesis Molecular AI Basic Information, Manufacturing Base and Competitors
Table 102. Genesis Molecular AI Major Business
Table 103. Genesis Molecular AI AI-Designed Small-Molecule Drugs Product and Services
Table 104. Genesis Molecular AI AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Genesis Molecular AI Recent Developments/Updates
Table 106. Terray Therapeutics Basic Information, Manufacturing Base and Competitors
Table 107. Terray Therapeutics Major Business
Table 108. Terray Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 109. Terray Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Terray Therapeutics Recent Developments/Updates
Table 111. CHARM Therapeutics Basic Information, Manufacturing Base and Competitors
Table 112. CHARM Therapeutics Major Business
Table 113. CHARM Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 114. CHARM Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. CHARM Therapeutics Recent Developments/Updates
Table 116. Anagenex Basic Information, Manufacturing Base and Competitors
Table 117. Anagenex Major Business
Table 118. Anagenex AI-Designed Small-Molecule Drugs Product and Services
Table 119. Anagenex AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Anagenex Recent Developments/Updates
Table 121. StoneWise Basic Information, Manufacturing Base and Competitors
Table 122. StoneWise Major Business
Table 123. StoneWise AI-Designed Small-Molecule Drugs Product and Services
Table 124. StoneWise AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. StoneWise Recent Developments/Updates
Table 126. Global AI-Designed Small-Molecule Drugs Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 127. Global AI-Designed Small-Molecule Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 128. Global AI-Designed Small-Molecule Drugs Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 129. Market Position of Manufacturers in AI-Designed Small-Molecule Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 130. Head Office and AI-Designed Small-Molecule Drugs Production Site of Key Manufacturer
Table 131. AI-Designed Small-Molecule Drugs Market: Company Product Type Footprint
Table 132. AI-Designed Small-Molecule Drugs Market: Company Product Application Footprint
Table 133. AI-Designed Small-Molecule Drugs New Market Entrants and Barriers to Market Entry
Table 134. AI-Designed Small-Molecule Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 135. Global AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 136. Global AI-Designed Small-Molecule Drugs Sales Quantity by Region (2021-2026) & (K Dose)
Table 137. Global AI-Designed Small-Molecule Drugs Sales Quantity by Region (2027-2032) & (K Dose)
Table 138. Global AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 139. Global AI-Designed Small-Molecule Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 140. Global AI-Designed Small-Molecule Drugs Average Price by Region (2021-2026) & (US$/Dose)
Table 141. Global AI-Designed Small-Molecule Drugs Average Price by Region (2027-2032) & (US$/Dose)
Table 142. Global AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 143. Global AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 144. Global AI-Designed Small-Molecule Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 145. Global AI-Designed Small-Molecule Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 146. Global AI-Designed Small-Molecule Drugs Average Price by Type (2021-2026) & (US$/Dose)
Table 147. Global AI-Designed Small-Molecule Drugs Average Price by Type (2027-2032) & (US$/Dose)
Table 148. Global AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 149. Global AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 150. Global AI-Designed Small-Molecule Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 151. Global AI-Designed Small-Molecule Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 152. Global AI-Designed Small-Molecule Drugs Average Price by Application (2021-2026) & (US$/Dose)
Table 153. Global AI-Designed Small-Molecule Drugs Average Price by Application (2027-2032) & (US$/Dose)
Table 154. North America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 155. North America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 156. North America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 157. North America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 158. North America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 159. North America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 160. North America AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 161. North America AI-Designed Small-Molecule Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 162. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 163. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 164. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 165. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 166. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 167. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 168. Europe AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 169. Europe AI-Designed Small-Molecule Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 170. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 171. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 172. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 173. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 174. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Region (2021-2026) & (K Dose)
Table 175. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Region (2027-2032) & (K Dose)
Table 176. Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 177. Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 178. South America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 179. South America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 180. South America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 181. South America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 182. South America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 183. South America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 184. South America AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 185. South America AI-Designed Small-Molecule Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 186. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 187. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 188. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 189. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 190. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 191. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 192. Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 193. Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 194. AI-Designed Small-Molecule Drugs Raw Material
Table 195. Key Manufacturers of AI-Designed Small-Molecule Drugs Raw Materials
Table 196. AI-Designed Small-Molecule Drugs Typical Distributors
Table 197. AI-Designed Small-Molecule Drugs Typical Customers
Table 1. Global AI-Designed Small-Molecule Drugs Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global AI-Designed Small-Molecule Drugs Consumption Value by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Table 3. Global AI-Designed Small-Molecule Drugs Consumption Value by Route of Administration, (USD Million), 2021 & 2025 & 2032
Table 4. Global AI-Designed Small-Molecule Drugs Consumption Value by Target Class, (USD Million), 2021 & 2025 & 2032
Table 5. Global AI-Designed Small-Molecule Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 6. Recursion Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 7. Recursion Pharmaceuticals Major Business
Table 8. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Product and Services
Table 9. Recursion Pharmaceuticals AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 10. Recursion Pharmaceuticals Recent Developments/Updates
Table 11. Insilico Medicine Basic Information, Manufacturing Base and Competitors
Table 12. Insilico Medicine Major Business
Table 13. Insilico Medicine AI-Designed Small-Molecule Drugs Product and Services
Table 14. Insilico Medicine AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 15. Insilico Medicine Recent Developments/Updates
Table 16. Schr?dinger Basic Information, Manufacturing Base and Competitors
Table 17. Schr?dinger Major Business
Table 18. Schr?dinger AI-Designed Small-Molecule Drugs Product and Services
Table 19. Schr?dinger AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 20. Schr?dinger Recent Developments/Updates
Table 21. XtalPi Basic Information, Manufacturing Base and Competitors
Table 22. XtalPi Major Business
Table 23. XtalPi AI-Designed Small-Molecule Drugs Product and Services
Table 24. XtalPi AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. XtalPi Recent Developments/Updates
Table 26. Isomorphic Labs Basic Information, Manufacturing Base and Competitors
Table 27. Isomorphic Labs Major Business
Table 28. Isomorphic Labs AI-Designed Small-Molecule Drugs Product and Services
Table 29. Isomorphic Labs AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Isomorphic Labs Recent Developments/Updates
Table 31. Relay Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Relay Therapeutics Major Business
Table 33. Relay Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 34. Relay Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Relay Therapeutics Recent Developments/Updates
Table 36. Nimbus Therapeutics Basic Information, Manufacturing Base and Competitors
Table 37. Nimbus Therapeutics Major Business
Table 38. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 39. Nimbus Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Nimbus Therapeutics Recent Developments/Updates
Table 41. Iambic Therapeutics Basic Information, Manufacturing Base and Competitors
Table 42. Iambic Therapeutics Major Business
Table 43. Iambic Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 44. Iambic Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. Iambic Therapeutics Recent Developments/Updates
Table 46. BenevolentAI Basic Information, Manufacturing Base and Competitors
Table 47. BenevolentAI Major Business
Table 48. BenevolentAI AI-Designed Small-Molecule Drugs Product and Services
Table 49. BenevolentAI AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. BenevolentAI Recent Developments/Updates
Table 51. Accutar Biotechnology Basic Information, Manufacturing Base and Competitors
Table 52. Accutar Biotechnology Major Business
Table 53. Accutar Biotechnology AI-Designed Small-Molecule Drugs Product and Services
Table 54. Accutar Biotechnology AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Accutar Biotechnology Recent Developments/Updates
Table 56. MindRank AI Basic Information, Manufacturing Base and Competitors
Table 57. MindRank AI Major Business
Table 58. MindRank AI AI-Designed Small-Molecule Drugs Product and Services
Table 59. MindRank AI AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. MindRank AI Recent Developments/Updates
Table 61. Enveda Biosciences Basic Information, Manufacturing Base and Competitors
Table 62. Enveda Biosciences Major Business
Table 63. Enveda Biosciences AI-Designed Small-Molecule Drugs Product and Services
Table 64. Enveda Biosciences AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 65. Enveda Biosciences Recent Developments/Updates
Table 66. Insitro Basic Information, Manufacturing Base and Competitors
Table 67. Insitro Major Business
Table 68. Insitro AI-Designed Small-Molecule Drugs Product and Services
Table 69. Insitro AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 70. Insitro Recent Developments/Updates
Table 71. Valo Health Basic Information, Manufacturing Base and Competitors
Table 72. Valo Health Major Business
Table 73. Valo Health AI-Designed Small-Molecule Drugs Product and Services
Table 74. Valo Health AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 75. Valo Health Recent Developments/Updates
Table 76. Healx Basic Information, Manufacturing Base and Competitors
Table 77. Healx Major Business
Table 78. Healx AI-Designed Small-Molecule Drugs Product and Services
Table 79. Healx AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 80. Healx Recent Developments/Updates
Table 81. Lantern Pharma Basic Information, Manufacturing Base and Competitors
Table 82. Lantern Pharma Major Business
Table 83. Lantern Pharma AI-Designed Small-Molecule Drugs Product and Services
Table 84. Lantern Pharma AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 85. Lantern Pharma Recent Developments/Updates
Table 86. Verge Labs Basic Information, Manufacturing Base and Competitors
Table 87. Verge Labs Major Business
Table 88. Verge Labs AI-Designed Small-Molecule Drugs Product and Services
Table 89. Verge Labs AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 90. Verge Labs Recent Developments/Updates
Table 91. DeepCure Basic Information, Manufacturing Base and Competitors
Table 92. DeepCure Major Business
Table 93. DeepCure AI-Designed Small-Molecule Drugs Product and Services
Table 94. DeepCure AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 95. DeepCure Recent Developments/Updates
Table 96. AQEMIA Basic Information, Manufacturing Base and Competitors
Table 97. AQEMIA Major Business
Table 98. AQEMIA AI-Designed Small-Molecule Drugs Product and Services
Table 99. AQEMIA AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 100. AQEMIA Recent Developments/Updates
Table 101. Genesis Molecular AI Basic Information, Manufacturing Base and Competitors
Table 102. Genesis Molecular AI Major Business
Table 103. Genesis Molecular AI AI-Designed Small-Molecule Drugs Product and Services
Table 104. Genesis Molecular AI AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 105. Genesis Molecular AI Recent Developments/Updates
Table 106. Terray Therapeutics Basic Information, Manufacturing Base and Competitors
Table 107. Terray Therapeutics Major Business
Table 108. Terray Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 109. Terray Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 110. Terray Therapeutics Recent Developments/Updates
Table 111. CHARM Therapeutics Basic Information, Manufacturing Base and Competitors
Table 112. CHARM Therapeutics Major Business
Table 113. CHARM Therapeutics AI-Designed Small-Molecule Drugs Product and Services
Table 114. CHARM Therapeutics AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 115. CHARM Therapeutics Recent Developments/Updates
Table 116. Anagenex Basic Information, Manufacturing Base and Competitors
Table 117. Anagenex Major Business
Table 118. Anagenex AI-Designed Small-Molecule Drugs Product and Services
Table 119. Anagenex AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 120. Anagenex Recent Developments/Updates
Table 121. StoneWise Basic Information, Manufacturing Base and Competitors
Table 122. StoneWise Major Business
Table 123. StoneWise AI-Designed Small-Molecule Drugs Product and Services
Table 124. StoneWise AI-Designed Small-Molecule Drugs Sales Quantity (K Dose), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 125. StoneWise Recent Developments/Updates
Table 126. Global AI-Designed Small-Molecule Drugs Sales Quantity by Manufacturer (2021-2026) & (K Dose)
Table 127. Global AI-Designed Small-Molecule Drugs Revenue by Manufacturer (2021-2026) & (USD Million)
Table 128. Global AI-Designed Small-Molecule Drugs Average Price by Manufacturer (2021-2026) & (US$/Dose)
Table 129. Market Position of Manufacturers in AI-Designed Small-Molecule Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 130. Head Office and AI-Designed Small-Molecule Drugs Production Site of Key Manufacturer
Table 131. AI-Designed Small-Molecule Drugs Market: Company Product Type Footprint
Table 132. AI-Designed Small-Molecule Drugs Market: Company Product Application Footprint
Table 133. AI-Designed Small-Molecule Drugs New Market Entrants and Barriers to Market Entry
Table 134. AI-Designed Small-Molecule Drugs Mergers, Acquisition, Agreements, and Collaborations
Table 135. Global AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 136. Global AI-Designed Small-Molecule Drugs Sales Quantity by Region (2021-2026) & (K Dose)
Table 137. Global AI-Designed Small-Molecule Drugs Sales Quantity by Region (2027-2032) & (K Dose)
Table 138. Global AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 139. Global AI-Designed Small-Molecule Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 140. Global AI-Designed Small-Molecule Drugs Average Price by Region (2021-2026) & (US$/Dose)
Table 141. Global AI-Designed Small-Molecule Drugs Average Price by Region (2027-2032) & (US$/Dose)
Table 142. Global AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 143. Global AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 144. Global AI-Designed Small-Molecule Drugs Consumption Value by Type (2021-2026) & (USD Million)
Table 145. Global AI-Designed Small-Molecule Drugs Consumption Value by Type (2027-2032) & (USD Million)
Table 146. Global AI-Designed Small-Molecule Drugs Average Price by Type (2021-2026) & (US$/Dose)
Table 147. Global AI-Designed Small-Molecule Drugs Average Price by Type (2027-2032) & (US$/Dose)
Table 148. Global AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 149. Global AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 150. Global AI-Designed Small-Molecule Drugs Consumption Value by Application (2021-2026) & (USD Million)
Table 151. Global AI-Designed Small-Molecule Drugs Consumption Value by Application (2027-2032) & (USD Million)
Table 152. Global AI-Designed Small-Molecule Drugs Average Price by Application (2021-2026) & (US$/Dose)
Table 153. Global AI-Designed Small-Molecule Drugs Average Price by Application (2027-2032) & (US$/Dose)
Table 154. North America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 155. North America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 156. North America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 157. North America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 158. North America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 159. North America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 160. North America AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 161. North America AI-Designed Small-Molecule Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 162. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 163. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 164. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 165. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 166. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 167. Europe AI-Designed Small-Molecule Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 168. Europe AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 169. Europe AI-Designed Small-Molecule Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 170. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 171. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 172. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 173. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 174. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Region (2021-2026) & (K Dose)
Table 175. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity by Region (2027-2032) & (K Dose)
Table 176. Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value by Region (2021-2026) & (USD Million)
Table 177. Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value by Region (2027-2032) & (USD Million)
Table 178. South America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 179. South America AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 180. South America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 181. South America AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 182. South America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 183. South America AI-Designed Small-Molecule Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 184. South America AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 185. South America AI-Designed Small-Molecule Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 186. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Type (2021-2026) & (K Dose)
Table 187. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Type (2027-2032) & (K Dose)
Table 188. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Application (2021-2026) & (K Dose)
Table 189. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Application (2027-2032) & (K Dose)
Table 190. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Country (2021-2026) & (K Dose)
Table 191. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity by Country (2027-2032) & (K Dose)
Table 192. Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value by Country (2021-2026) & (USD Million)
Table 193. Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value by Country (2027-2032) & (USD Million)
Table 194. AI-Designed Small-Molecule Drugs Raw Material
Table 195. Key Manufacturers of AI-Designed Small-Molecule Drugs Raw Materials
Table 196. AI-Designed Small-Molecule Drugs Typical Distributors
Table 197. AI-Designed Small-Molecule Drugs Typical Customers
LIST OF FIGURES
Figure 1. AI-Designed Small-Molecule Drugs Picture
Figure 2. Global AI-Designed Small-Molecule Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Type in 2025
Figure 4. Discovery-Stage Candidates Examples
Figure 5. Preclinical Candidates Examples
Figure 6. Clinical-Stage Candidates Examples
Figure 7. Approved Drugs Examples
Figure 8. Global AI-Designed Small-Molecule Drugs Revenue by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Figure 9. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Mechanism of Action in 2025
Figure 10. Enzyme Inhibitors Examples
Figure 11. Receptor Agonists Examples
Figure 12. Receptor Antagonists Examples
Figure 13. Targeted Protein Degraders Examples
Figure 14. Molecular Glues Examples
Figure 15. Other Small-Molecule Modulators Examples
Figure 16. Global AI-Designed Small-Molecule Drugs Revenue by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 17. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Route of Administration in 2025
Figure 18. Oral Drugs Examples
Figure 19. Injectable Drugs Examples
Figure 20. Inhaled Drugs Examples
Figure 21. Topical Drugs Examples
Figure 22. Other Administration Routes Examples
Figure 23. Global AI-Designed Small-Molecule Drugs Revenue by Target Class, (USD Million), 2021 & 2025 & 2032
Figure 24. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Target Class in 2025
Figure 25. Kinases Examples
Figure 26. Other Enzymes Examples
Figure 27. G Protein-Coupled Receptors Examples
Figure 28. Nuclear Receptors Examples
Figure 29. Protein?Protein Interaction Targets Examples
Figure 30. Nucleic Acid Targets Examples
Figure 31. Other Target Classes Examples
Figure 32. Other Target Classes Examples
Figure 33. Global AI-Designed Small-Molecule Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 34. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Application in 2025
Figure 35. Oncology Examples
Figure 36. Immunology and Inflammation Examples
Figure 37. Neurology and Psychiatry Examples
Figure 38. Metabolic and Cardiovascular Diseases Examples
Figure 39. Infectious Diseases Examples
Figure 40. Other Therapeutic Areas Examples
Figure 41. Global AI-Designed Small-Molecule Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 42. Global AI-Designed Small-Molecule Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 43. Global AI-Designed Small-Molecule Drugs Sales Quantity (2021-2032) & (K Dose)
Figure 44. Global AI-Designed Small-Molecule Drugs Price (2021-2032) & (US$/Dose)
Figure 45. Global AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 46. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Manufacturer in 2025
Figure 47. Producer Shipments of AI-Designed Small-Molecule Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 48. Top 3 AI-Designed Small-Molecule Drugs Manufacturer (Revenue) Market Share in 2025
Figure 49. Top 6 AI-Designed Small-Molecule Drugs Manufacturer (Revenue) Market Share in 2025
Figure 50. Global AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 51. Global AI-Designed Small-Molecule Drugs Consumption Value Market Share by Region (2021-2032)
Figure 52. North America AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. South America AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. Global AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 58. Global AI-Designed Small-Molecule Drugs Consumption Value Market Share by Type (2021-2032)
Figure 59. Global AI-Designed Small-Molecule Drugs Average Price by Type (2021-2032) & (US$/Dose)
Figure 60. Global AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 61. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Application (2021-2032)
Figure 62. Global AI-Designed Small-Molecule Drugs Average Price by Application (2021-2032) & (US$/Dose)
Figure 63. North America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 64. North America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 65. North America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 66. North America AI-Designed Small-Molecule Drugs Consumption Value Market Share by Country (2021-2032)
Figure 67. United States AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 68. Canada AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 69. Mexico AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. Europe AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 71. Europe AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 72. Europe AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 73. Europe AI-Designed Small-Molecule Drugs Consumption Value Market Share by Country (2021-2032)
Figure 74. Germany AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 75. France AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. United Kingdom AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 77. Russia AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 78. Italy AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 79. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 80. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 81. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 82. Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value Market Share by Region (2021-2032)
Figure 83. China AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 84. Japan AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 85. South Korea AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 86. India AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 87. Southeast Asia AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 88. Australia AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 89. South America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 90. South America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 91. South America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 92. South America AI-Designed Small-Molecule Drugs Consumption Value Market Share by Country (2021-2032)
Figure 93. Brazil AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 94. Argentina AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 95. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 96. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 97. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 98. Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value Market Share by Country (2021-2032)
Figure 99. Turkey AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 100. Egypt AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 101. Saudi Arabia AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 102. South Africa AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 103. AI-Designed Small-Molecule Drugs Market Drivers
Figure 104. AI-Designed Small-Molecule Drugs Market Restraints
Figure 105. AI-Designed Small-Molecule Drugs Market Trends
Figure 106. Porters Five Forces Analysis
Figure 107. Manufacturing Cost Structure Analysis of AI-Designed Small-Molecule Drugs in 2025
Figure 108. Manufacturing Process Analysis of AI-Designed Small-Molecule Drugs
Figure 109. AI-Designed Small-Molecule Drugs Industrial Chain
Figure 110. Sales Channel: Direct to End-User vs Distributors
Figure 111. Direct Channel Pros & Cons
Figure 112. Indirect Channel Pros & Cons
Figure 113. Methodology
Figure 114. Research Process and Data Source
Figure 1. AI-Designed Small-Molecule Drugs Picture
Figure 2. Global AI-Designed Small-Molecule Drugs Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Type in 2025
Figure 4. Discovery-Stage Candidates Examples
Figure 5. Preclinical Candidates Examples
Figure 6. Clinical-Stage Candidates Examples
Figure 7. Approved Drugs Examples
Figure 8. Global AI-Designed Small-Molecule Drugs Revenue by Mechanism of Action, (USD Million), 2021 & 2025 & 2032
Figure 9. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Mechanism of Action in 2025
Figure 10. Enzyme Inhibitors Examples
Figure 11. Receptor Agonists Examples
Figure 12. Receptor Antagonists Examples
Figure 13. Targeted Protein Degraders Examples
Figure 14. Molecular Glues Examples
Figure 15. Other Small-Molecule Modulators Examples
Figure 16. Global AI-Designed Small-Molecule Drugs Revenue by Route of Administration, (USD Million), 2021 & 2025 & 2032
Figure 17. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Route of Administration in 2025
Figure 18. Oral Drugs Examples
Figure 19. Injectable Drugs Examples
Figure 20. Inhaled Drugs Examples
Figure 21. Topical Drugs Examples
Figure 22. Other Administration Routes Examples
Figure 23. Global AI-Designed Small-Molecule Drugs Revenue by Target Class, (USD Million), 2021 & 2025 & 2032
Figure 24. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Target Class in 2025
Figure 25. Kinases Examples
Figure 26. Other Enzymes Examples
Figure 27. G Protein-Coupled Receptors Examples
Figure 28. Nuclear Receptors Examples
Figure 29. Protein?Protein Interaction Targets Examples
Figure 30. Nucleic Acid Targets Examples
Figure 31. Other Target Classes Examples
Figure 32. Other Target Classes Examples
Figure 33. Global AI-Designed Small-Molecule Drugs Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 34. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Application in 2025
Figure 35. Oncology Examples
Figure 36. Immunology and Inflammation Examples
Figure 37. Neurology and Psychiatry Examples
Figure 38. Metabolic and Cardiovascular Diseases Examples
Figure 39. Infectious Diseases Examples
Figure 40. Other Therapeutic Areas Examples
Figure 41. Global AI-Designed Small-Molecule Drugs Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 42. Global AI-Designed Small-Molecule Drugs Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 43. Global AI-Designed Small-Molecule Drugs Sales Quantity (2021-2032) & (K Dose)
Figure 44. Global AI-Designed Small-Molecule Drugs Price (2021-2032) & (US$/Dose)
Figure 45. Global AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Manufacturer in 2025
Figure 46. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Manufacturer in 2025
Figure 47. Producer Shipments of AI-Designed Small-Molecule Drugs by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 48. Top 3 AI-Designed Small-Molecule Drugs Manufacturer (Revenue) Market Share in 2025
Figure 49. Top 6 AI-Designed Small-Molecule Drugs Manufacturer (Revenue) Market Share in 2025
Figure 50. Global AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 51. Global AI-Designed Small-Molecule Drugs Consumption Value Market Share by Region (2021-2032)
Figure 52. North America AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 53. Europe AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 54. Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 55. South America AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 56. Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 57. Global AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 58. Global AI-Designed Small-Molecule Drugs Consumption Value Market Share by Type (2021-2032)
Figure 59. Global AI-Designed Small-Molecule Drugs Average Price by Type (2021-2032) & (US$/Dose)
Figure 60. Global AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 61. Global AI-Designed Small-Molecule Drugs Revenue Market Share by Application (2021-2032)
Figure 62. Global AI-Designed Small-Molecule Drugs Average Price by Application (2021-2032) & (US$/Dose)
Figure 63. North America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 64. North America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 65. North America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 66. North America AI-Designed Small-Molecule Drugs Consumption Value Market Share by Country (2021-2032)
Figure 67. United States AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 68. Canada AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 69. Mexico AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 70. Europe AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 71. Europe AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 72. Europe AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 73. Europe AI-Designed Small-Molecule Drugs Consumption Value Market Share by Country (2021-2032)
Figure 74. Germany AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 75. France AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 76. United Kingdom AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 77. Russia AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 78. Italy AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 79. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 80. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 81. Asia-Pacific AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Region (2021-2032)
Figure 82. Asia-Pacific AI-Designed Small-Molecule Drugs Consumption Value Market Share by Region (2021-2032)
Figure 83. China AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 84. Japan AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 85. South Korea AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 86. India AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 87. Southeast Asia AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 88. Australia AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 89. South America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 90. South America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 91. South America AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 92. South America AI-Designed Small-Molecule Drugs Consumption Value Market Share by Country (2021-2032)
Figure 93. Brazil AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 94. Argentina AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 95. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Type (2021-2032)
Figure 96. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Application (2021-2032)
Figure 97. Middle East & Africa AI-Designed Small-Molecule Drugs Sales Quantity Market Share by Country (2021-2032)
Figure 98. Middle East & Africa AI-Designed Small-Molecule Drugs Consumption Value Market Share by Country (2021-2032)
Figure 99. Turkey AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 100. Egypt AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 101. Saudi Arabia AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 102. South Africa AI-Designed Small-Molecule Drugs Consumption Value (2021-2032) & (USD Million)
Figure 103. AI-Designed Small-Molecule Drugs Market Drivers
Figure 104. AI-Designed Small-Molecule Drugs Market Restraints
Figure 105. AI-Designed Small-Molecule Drugs Market Trends
Figure 106. Porters Five Forces Analysis
Figure 107. Manufacturing Cost Structure Analysis of AI-Designed Small-Molecule Drugs in 2025
Figure 108. Manufacturing Process Analysis of AI-Designed Small-Molecule Drugs
Figure 109. AI-Designed Small-Molecule Drugs Industrial Chain
Figure 110. Sales Channel: Direct to End-User vs Distributors
Figure 111. Direct Channel Pros & Cons
Figure 112. Indirect Channel Pros & Cons
Figure 113. Methodology
Figure 114. Research Process and Data Source
